Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“Prognostic impact of molecular alterations in resected lung adeno and implications for TNM 10th edition.
EGFR, TP53, KRAS and ALK
TP53/KRAS: potential potential in stage I
ALK: downstaging potential in stages III–IV.”
Title: Brief Report: The Prognostic Impact of Common Molecular Alterations in Resected Lung Adenocarcinoma and Implications for the 10th Edition TNM Classification
Authors: Huatao Tang, Chaoqiang Deng, Hang Cao, Fangqiu Fu, Molin Zhang, Wangyang Zhu, Yuan Li, Yang Zhang, Haiquan Chen
Read the Full Article.
Other articles featuring Hidehito Horinouchi on OncoDaily.